The pandemic has accelerated the adoption of molecular diagnostics devices and equipment in the healthcare industry, highlighting the power of sequencing-based diagnostic testing in global efforts to combat the spread of the infectious diseases, and its importance in supporting recovery efforts.

“Had [the US] done more testing from the very beginning and caught cases earlier,” said Dr. Nuzzo of Johns Hopkins, “we would be in a far different place.”

Roche, Hologic, and Thermo Fisher Scientific are among the molecular diagnostic vendors that have received EUAs, or emergency use authorizations, for their tests for the novel coronavirus COVID-19.  

Carrier screening revolves around the gene testing of individuals to understand whether a person is carrying the gene for certain genetic disorders. This test can be performed before or during the time of pregnancy to evaluate the possibility of the baby carrying any type of genetic disease.

In vitro diagnostic testing costs little to the healthcare system and contributes much to clinical practice.  

In vitro diagnostics (IVD) is a growing market, which is one of the reasons that so many companies need to continue to track the market using market research aids. In our latest study The Worldwide Market for In Vitro Diagnostic Tests: 12 Edition, Kalorama Information estimates the in vitro diagnostics market size at $69 billion and growing at 4%, with many sectors of the IVD market growing double that.  

The U.S. is the largest medical imaging market globally due to the high disposable income and health insurance of consumers. More than 630 million X-rays, CT & PET scans, MRIs, ultrasounds, and mammographies are performed each year, representing an important part of the healthcare system.

According to a new report from Marketdata, the fertility clinics industry in the United States is booming, thanks to growing demand from American couples that have delayed childbearing, more widespread acceptance of fertility treatment and usage by gay couples, improved success rates, a strong economy, and significant demand from medical tourists coming from Europe and China. The industry is fragmented, largely untapped, and is ripe for consolidation.

The in vitro diagnostics market continues to attract the interest of investors and healthcare providers alike. Clinical testing is used for 70 percent of healthcare decisions and can help provide more targeted therapy at a lower cost.

Growth in the pet population, increasing penetration of pet insurance, pet humanization within the growing global urban population and increased awareness of animal welfare needs due to social media are helping the veterinary industry to maintain growth at 6.2% a year, according to a new market research report.

The process of diagnosis uses data collection and complex analysis to determine a patient’s health and course of treatment. Accurate diagnosis is the most critical aspect of health care.